The Food and Drug Administration has approved a new non-hormonal pill to treat hot flashes and night sweats brought on by menopause. Dr. Joann Pinkerton, professor of obstetrics and gynecology at the University of Virginia Health System and one of the drug's trial investigators explains how the medication works.
Breakdown
- FDA approves Linquid, a non-hormonal pill for menopause-related hot flashes and night sweats.
- Linquid targets brain receptors NK1 and NK3 to regulate body temperature. 1m 2s
- Clinical trials showed significant reduction in hot flashes and improved sleep. 15s
- The medication is suitable for women who cannot or choose not to take hormone therapy. 44s
- Linquid will be available by prescription, with efforts underway to reduce its cost. 1m 54s